Sun Pharmaceutical Industries Ltd. on Thursday said it will buy out local partner Indi Pharma from its Mexican arm for MXN 161.85 million (over Rs 75 crore).
The company has signed a binding letter of intent to acquire the balance 25% outstanding shares of Sun Pharma de Mexico, SA de CV, a subsidiary where it currently holds 75% shares, Sun Pharmaceutical Industries said in a regulatory filing.
The balance of 25% is held by local partner Indi Pharma S.A.P.I. de CV, it added.
The cost of acquisition is MXN 161.85 million, it added.
"The acquisition enables Sun Pharma to acquire the balance 25% stake held by the local partner," the company said, adding it would be done through a wholly-owned subsidiary Sun Pharma (Netherlands) B.V.
The acquisition is likely to be completed by Oct. 31, 2023, and after that, Sun Pharma de Mexico SA de CV will become a wholly-owned subsidiary of the company, it said.
Sun Pharma de Mexico is engaged in the marketing and distribution of pharmaceutical products in Mexico.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
